How can I differentiate acute tubular necrosis (ATN), renal cortical necrosis (RCN), and postpartum atypical hemolytic‑uremic syndrome (aHUS) in a postpartum woman?

Differentiating ATN vs. Renal Cortical Necrosis vs. Postpartum aHUS

In a postpartum woman with acute kidney injury, the presence of microangiopathic hemolytic anemia (MAHA) with thrombocytopenia immediately points toward aHUS or RCN rather than ATN, as ATN does not cause hemolysis or thrombocytopenia. The key is recognizing that over 50% of postpartum RCN cases are actually caused by underlying aHUS with thrombotic microangiopathy 1, 2.

Immediate Laboratory Assessment

When encountering anemia plus thrombocytopenia in the postpartum setting, immediately measure haptoglobin, indirect bilirubin, and LDH levels 3. This triad of tests distinguishes isolated kidney injury from systemic thrombotic microangiopathy.

ATN Presentation

• Isolated acute kidney injury without systemic features
• No hemolysis: Normal hemoglobin trajectory, normal LDH, normal haptoglobin
• No thrombocytopenia: Platelet count remains normal or shows expected postpartum changes
• Typically follows clear precipitant: hemorrhage, sepsis, nephrotoxic medications
• Urine sediment shows muddy brown casts
• Recovery expected within days to weeks with supportive care

Postpartum aHUS Features

aHUS presents with the diagnostic triad 3:

• Microangiopathic hemolytic anemia: Elevated LDH, reduced haptoglobin, negative direct Coombs test, schistocytes on peripheral smear (though >1% schistocytes favors TMA, their absence does not exclude it 3)
• Thrombocytopenia: Platelets <150,000/mm³ or 25% reduction from baseline
• Acute kidney injury: Elevated creatinine, hematuria, and/or proteinuria

Critical timing: aHUS most commonly presents postpartum (94% of first-episode cases), often after cesarean delivery (70%), and frequently in nulliparous women (58%) 4. Preceding obstetric complications are common: fetal death, preeclampsia, hemorrhage 4.

Laboratory evolution distinguishes aHUS from RCN 1:

• In aHUS without extensive necrosis: Hemoglobin, platelets, and liver enzymes improve over 10-14 days
• Creatinine remains elevated despite hematologic improvement
• ADAMTS13 activity must be >10% to exclude TTP 3

Renal Cortical Necrosis Presentation

RCN represents the most severe end of the spectrum and is frequently associated with aHUS 1, 2. In a recent series, 95.2% of postpartum RCN cases showed microangiopathic hemolytic anemia consistent with aHUS 2.

Distinguishing features of RCN:

• All patients exhibit hemolysis, thrombocytopenia, and elevated liver enzymes immediately postpartum 1
• Persistent anuria is highly suggestive
• Over 11-12 days, hemoglobin, platelets, and liver enzymes improve significantly, but creatinine remains unchanged 1
• Imaging confirmation: Contrast-enhanced CT shows non-enhancing renal cortex with enhancing medulla and no contrast excretion 2
• Kidney biopsy (when feasible): 52.2% show thrombotic microangiopathy; diffuse vs. partial necrosis predicts recovery 1

Poor prognostic indicators for RCN 1:

• Diffuse cortical necrosis on biopsy
• Persistent anuria
• Dialysis dependence at discharge
• Elevated LDH and D-dimer at follow-up

Diagnostic Algorithm

Step 1: Assess for TMA Triad

• Hemolysis markers (LDH, haptoglobin, indirect bilirubin, schistocytes)
• Platelet count
• Renal function (creatinine, urinalysis)

If all three present → Proceed to Step 2
If absent → Consider ATN (isolated AKI without hemolysis/thrombocytopenia)

Step 2: Exclude Other TMAs

• ADAMTS13 activity: Must be >10% (if <10%, diagnose TTP) 3
• Stool culture for VTEC/Shiga toxin: Exclude STEC-HUS 3
• Timing: STEC-HUS appears 4-5 days after diarrhea onset; if diarrhea and HUS are concurrent, suspect aHUS 3

Step 3: Determine Extent of Renal Injury

• Urine output monitoring: Persistent anuria suggests RCN
• Contrast-enhanced CT if available: Defines cortical necrosis extent
• Complement levels: Low C3 or alternate pathway activation supports aHUS (seen in 60% when tested) 2

Step 4: Clinical Context Integration

Pregnancy is a recognized trigger for aHUS 3. The postpartum period represents a high-risk window, particularly after:

• Cesarean delivery
• Obstetric hemorrhage
• Placental abruption
• Puerperal sepsis
• Preeclampsia/HELLP syndrome

Critical Management Implications

The distinction between aHUS and ATN is life-threatening because aHUS requires immediate complement blockade 4, 5.

• ATN: Supportive care, address precipitant, expect recovery
• aHUS without extensive RCN: Eculizumab within 24 hours of clinical suspicion 5. In first-episode pregnancy-associated aHUS, 88% achieved remission with eculizumab vs. 57% without (p=0.02) 4
• RCN with aHUS: Eculizumab plus renal replacement therapy; only 9.5% achieve partial recovery, 66.7% remain dialysis-dependent 2

Common Pitfalls

1. Assuming postpartum AKI is always ATN from hemorrhage/sepsis: This misses the TMA diagnosis. Always check hemolysis markers.

2. Waiting for genetic testing results: aHUS is a clinical diagnosis; genetic variants are found in only 60% of cases 3. Absence of mutations does not exclude aHUS.

3. Dismissing aHUS because complement levels are normal: Normal complement does not exclude aHUS 6. The diagnosis rests on clinical and laboratory TMA features with exclusion of other causes.

4. Assuming improvement in hemolysis/platelets means recovery: In RCN, hematologic parameters normalize while renal function remains severely impaired 1. This dissociation is characteristic.

5. Not recognizing that RCN and aHUS frequently coexist: RCN is not a separate entity but often represents severe aHUS-mediated thrombotic microangiopathy 1, 2. Over half of RCN biopsies show TMA.

6. Delaying imaging: If anuria persists beyond 48-72 hours despite hematologic improvement, obtain contrast-enhanced CT immediately to diagnose RCN and guide prognosis 1, 2.